Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sangani

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Surgery|November 28, 2017
Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipientsMichelle A Arms, James Fleming, Deep B Sangani, et al.
Mini Reviews in Medicinal Chemistry|August 25, 2016
Recent Developments of Metal and Metal Oxide Nanocatalysts in Organic SynthesisJigar A Makawana, Chetan B Sangani, Yong-Fang Yao, et al.
RSC Advances|June 24, 2022
Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACsMohd Muddassir, Kunjal Soni, Chetan B Sangani, et al.
Bioorganic Chemistry|April 7, 2024
PI3Kδ and mTOR dual inhibitors: Design, synthesis and anticancer evaluation of 3-substituted aminomethylquinoline analoguesDigambar Yevale, Nishith Teraiya, Twinkle Lalwani, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2014
Design, synthesis and molecular modeling of biquinoline-pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitorsChetan B Sangani, Jigar A Makawana, Yong-Tao Duan, et al.
Bulletin of the World Health Organization|January 1, 1990
Thalassemia in Bombay: the role of medical genetics in developing countriesB Sangani, P K Sukumaran, C Mahadik, et al.
Bioorganic & Medicinal Chemistry|February 20, 2015
6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3KαYong Yin, Yan-Qing Zhang, Biao Jin, et al.
Bioorganic & Medicinal Chemistry|December 16, 2014
Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitorsMeng-Yue Zhao, Yong Yin, Xiao-Wei Yu, et al.
European Journal of Medicinal Chemistry|October 10, 2024
Discovery of new pyrazole-4-carboxamide analogues as potential anticancer agents targeting dual aurora kinase A and BDigambar Yevale, Nishith Teraiya, Twinkle Lalwani, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Surgery|November 28, 2017
Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipientsMichelle A Arms, James Fleming, Deep B Sangani, et al.
Mini Reviews in Medicinal Chemistry|August 25, 2016
Recent Developments of Metal and Metal Oxide Nanocatalysts in Organic SynthesisJigar A Makawana, Chetan B Sangani, Yong-Fang Yao, et al.
RSC Advances|June 24, 2022
Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACsMohd Muddassir, Kunjal Soni, Chetan B Sangani, et al.
Bioorganic Chemistry|April 7, 2024
PI3Kδ and mTOR dual inhibitors: Design, synthesis and anticancer evaluation of 3-substituted aminomethylquinoline analoguesDigambar Yevale, Nishith Teraiya, Twinkle Lalwani, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2014
Design, synthesis and molecular modeling of biquinoline-pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitorsChetan B Sangani, Jigar A Makawana, Yong-Tao Duan, et al.
Bulletin of the World Health Organization|January 1, 1990
Thalassemia in Bombay: the role of medical genetics in developing countriesB Sangani, P K Sukumaran, C Mahadik, et al.
Bioorganic & Medicinal Chemistry|February 20, 2015
6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3KαYong Yin, Yan-Qing Zhang, Biao Jin, et al.
Bioorganic & Medicinal Chemistry|December 16, 2014
Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitorsMeng-Yue Zhao, Yong Yin, Xiao-Wei Yu, et al.
European Journal of Medicinal Chemistry|October 10, 2024
Discovery of new pyrazole-4-carboxamide analogues as potential anticancer agents targeting dual aurora kinase A and BDigambar Yevale, Nishith Teraiya, Twinkle Lalwani, et al.
Pageof 2